Grant Sweep

We sweep the internet for research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenP30Clinical trial: Not allowed

Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-27-054

Source: Grants.gov · View original posting ↗

Award
Amount not listed
Deadline
May 26, 2029
Letter of intent
Mechanism
P30
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Aug 19, 2026
Total funding
Clinical trial
Not allowed
Early careerHigher educationNonprofitGovernmentForeign entities

Research areas

Training & career development

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

The Institutional Development Awards (IDeA) program supports biomedical research capacity building in states that have historically received low levels of NIH funding. The Centers of Biomedical Research Excellence: Development Phase (COBRE-D) program supports institutions in IDeA states to increase their biomedical research capacity in a broad scientific area of strategic importance to them but for which they have limited existing infrastructure or expertise.COBRE-D supports a long-term institutional vision focused on the recruitment and mentoring of early-career investigators with supplemental start-up packages for new hires, the establishment of research facilities, and enhancement of research administration support services. This program serves as an on-ramp for less-resourced institutions to the Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) program. This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.

Data notes: award amount not published in the source feed; administering NIH institute could not be identified from the opportunity number.